Search - tctmd.com

Displaying 201 - 214 of 214

Sort: Relevancy | Date

News Daily News

Un Meta Análisis Cuestiona la Conveniencia de la PCI en la EAC Estable

L.A. McKeown

March 05, 2012

News Daily News

Meta-Analysis Questions Appropriateness of PCI in Stable CAD

L.A. McKeown

March 05, 2012

News Industry News

Independent Data Safety Monitoring Board Recommends St. Jude Medical’s FAME II Clinical Trial Stop Enrollment Following Positive Interim Analysis

January 17, 2012

Presentation TCT 2012

The Impact of XIENCE V® Everolimus-Eluting Coronary Stents on Health Status in COURAGE-Like Patients.

Presenter: David R. Rutledge, James B. Hermiller, Jin Wang, Mitchell W. Krucoff

January 03, 2012

News Daily News

BARI 2D: Older Age Makes No Difference in Therapies for Diabetics with Stable CAD

Leah Lawrence

August 09, 2011

News Daily News

CT Angiography Screening Unjustified, Study Finds

May 25, 2011

News Daily News

Since COURAGE, Little Change in Optimal Medical Therapy for Stable PCI Patients

Caitlin E. Cox

May 10, 2011

News Daily News

Substantial Decline Seen in CABG Over Last Decade, But PCI Rates Unchanged

L.A. McKeown

May 03, 2011

News Daily News

DES Add Over $1.5 Billion in Medicare Costs to Health Care System

Jason Kahn

April 28, 2011

News Daily News

The COURAGE Effect: Sustained Decline Seen in PCI for Stable Angina

Jason Kahn

April 25, 2011

News Conference News

STICH: CABG Does Not Extend Survival Over Medical Therapy in Heart Failure Patients

Caitlin E. Cox

April 04, 2011

News Conference News

PARTNER: TAVI Cost Effective Compared With Standard Care

Jason Kahn

April 03, 2011

News Daily News

Steady Decline Seen in PCI Use Over Last Few Years

L.A. McKeown

February 21, 2011

News Daily News

COURAGE: PCI Not Cost-Effective Even for Highly Symptomatic Patients

February 15, 2011

Advertisement

Un Meta Análisis Cuestiona la Conveniencia de la PCI en la EAC Estable

Meta-Analysis Questions Appropriateness of PCI in Stable CAD

Independent Data Safety Monitoring Board Recommends St. Jude Medical’s FAME II Clinical Trial Stop Enrollment Following Positive Interim Analysis

The Impact of XIENCE V® Everolimus-Eluting Coronary Stents on Health Status in COURAGE-Like Patients.

BARI 2D: Older Age Makes No Difference in Therapies for Diabetics with Stable CAD

CT Angiography Screening Unjustified, Study Finds

Since COURAGE, Little Change in Optimal Medical Therapy for Stable PCI Patients

Substantial Decline Seen in CABG Over Last Decade, But PCI Rates Unchanged

DES Add Over $1.5 Billion in Medicare Costs to Health Care System

The COURAGE Effect: Sustained Decline Seen in PCI for Stable Angina

STICH: CABG Does Not Extend Survival Over Medical Therapy in Heart Failure Patients

PARTNER: TAVI Cost Effective Compared With Standard Care

Steady Decline Seen in PCI Use Over Last Few Years

COURAGE: PCI Not Cost-Effective Even for Highly Symptomatic Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content